PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response

被引:421
|
作者
Zhang, Feng [2 ]
Ma, Jianglin [1 ]
Wu, Jiaxue [2 ]
Ye, Lin [2 ]
Cai, Hong [1 ]
Xia, Bing [1 ]
Yu, Xiaochun [2 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, Canc Inst New Jersey, New Brunswick, NJ 08903 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
FANCONI-ANEMIA; CANCER SUSCEPTIBILITY; S-PHASE; PHOSPHORYLATION; ATM; BACH1; RECOMBINATION; CHECKPOINT; PARTNER; PROTEIN;
D O I
10.1016/j.cub.2009.02.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BRCA1 and BRCA2 are often mutated in familial breast and ovarian cancer. Both tumor suppressors play key roles in the DNA-damage response [1, 2]. However, it remains unclear whether these two tumor suppressor function together in the same DNA-damage response pathway. Here, we show that BRCA1 associates with BRCA2 through PALB2/FANCN, a major binding partner of BRCA2 [3]. The interaction between BRCA1 and BRCA2 is abrogated in PAL132-deficient Fanconi anemia cells and in the cells depleted of PALB2 by small interfering RNA. Moreover, we show that BRCA1 promotes the concentration of PALB2 and BRCA2 at DNA-damage sites and the interaction between BRCA1 and PALB2 is important for the homologous recombination repair. Taken together, our results indicate that BRCA1 is an upstream regulator of BRCA2 in the DNA-damage response, and PALB2 is the linker between BRCA1 BRCA2.
引用
收藏
页码:524 / 529
页数:6
相关论文
共 50 条
  • [21] Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development
    Yanying Huo
    Pier Selenica
    Amar H. Mahdi
    Fresia Pareja
    Kelly Kyker-Snowman
    Ying Chen
    Rahul Kumar
    Arnaud Da Cruz Paula
    Thais Basili
    David N. Brown
    Xin Pei
    Nadeem Riaz
    Yongmei Tan
    Yu-Xiu Huang
    Tao Li
    Nicola J. Barnard
    Jorge S. Reis-Filho
    Britta Weigelt
    Bing Xia
    npj Breast Cancer, 7
  • [22] Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland
    Wojcik, P.
    Jasiowka, M.
    Strycharz, E.
    Sobol, M.
    Hodorowicz-Zaniewska, D.
    Skotnicki, P.
    Byrski, T.
    Blecharz, P.
    Marczyk, E.
    Cedrych, I.
    Jakubowicz, J.
    Lubinski, J.
    Sopik, V.
    Narod, S.
    Pierzchalski, P.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2016, 14
  • [23] Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland
    P. Wojcik
    M. Jasiowka
    E. Strycharz
    M. Sobol
    D. Hodorowicz-Zaniewska
    P. Skotnicki
    T. Byrski
    P. Blecharz
    E. Marczyk
    I. Cedrych
    J. Jakubowicz
    J. Lubiński
    V. Sopik
    S. Narod
    P. Pierzchalski
    Hereditary Cancer in Clinical Practice, 14
  • [24] Validation of a next generation sequencing assay for BRCA1, BRCA2, CHEK2 and PALB2 genetic testing
    Sim, Wey Cheng
    Lee, Chee Yang
    Richards, Rebecca
    Bettens, Karolien
    Mottier, Violaine
    Goh, Liuh Ling
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2020, 116
  • [25] Frequency of large rearrangements in BRCA1, BRCA2, ATM, CHEK2, and PALB2 in hereditary cancer testing
    Bissonnette, J.
    Doonanco, K.
    Xu, Z.
    Klein, R. T.
    Hruska, K. S.
    CANCER RESEARCH, 2016, 76
  • [26] The frequency of HER2-low breast cancer among BRCA1, BRCA2, and PALB2 mutation carriers
    Goldblatt, Lindsay
    Coutifaris, Paulina
    Shah, Payal Deepak
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development
    Huo, Yanying
    Selenica, Pier
    Mahdi, Amar H.
    Pareja, Fresia
    Kyker-Snowman, Kelly
    Chen, Ying
    Kumar, Rahul
    Da Cruz Paula, Arnaud
    Basili, Thais
    Brown, David N.
    Pei, Xin
    Riaz, Nadeem
    Tan, Yongmei
    Huang, Yu-Xiu
    Li, Tao
    Barnard, Nicola J.
    Reis-Filho, Jorge S.
    Weigelt, Britta
    Xia, Bing
    NPJ BREAST CANCER, 2021, 7 (01)
  • [28] Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma
    Shoko Takeuchi
    Manami Doi
    Naoki Ikari
    Masakazu Yamamoto
    Toru Furukawa
    Scientific Reports, 8
  • [29] BRCA1 and BRCA2
    Bertwistle, D
    Ashworth, A
    CURRENT BIOLOGY, 2000, 10 (16) : R582 - R582
  • [30] Characterising cancer risks for carriers of mutations in BRCA1, BRCA2, PALB2, and RAD51C genes
    Antoniou, Antonis C.
    CANCER RESEARCH, 2015, 75